 |
 |
|
North East and North Cumbria
ICS Formulary |
| Formulary Chapter 14: Immunological products and vaccines - Full Section
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
14.01 |
Active immunity (0,0)
|
|
|
Immunisation schedule (0,0)
|
|
14.02 |
Passive immunity (0,0)
|
|
14.03 |
Storage and use (0,0)
|
|
14.04 |
Vaccines and antisera
(2,0)
|
|
|
Anthrax vaccine (0,0)
|
|
|
BCG vaccines
(1,0)
|
|
|
Botulism antitoxin
(1,0)
|
|
|
Cholera vaccine (0,0)
|
|
|
COVID-19 vaccine
(1,0)
|
|
|
Diphtheria vaccines
(3,0)
|
|
|
Haemophilus influenzae type B vaccine
(2,0)
|
|
|
Hepatitis A vaccine
(2,0)
|
|
|
Hepatitis B vaccine
(1,0)
|
|
|
Human papilloma virus vaccine
(1,0)
|
|
|
Influenza vaccine
(1,0)
|
|
|
Measles vaccine (0,0)
|
|
|
Measles, Mumps and Rubella (MMR) vaccine
(1,0)
|
|
|
Meningococcal vaccines (0,0)
|
|
|
Mumps vaccine (0,0)
|
|
|
Pertussis vaccine (0,0)
|
|
|
Pneumococcal vaccines
(1,0)
|
|
|
Poliomyelitis vaccines
(2,0)
|
|
|
Rabies vaccine
(1,0)
|
|
|
Rotavirus vaccine
(1,0)
|
|
|
Rubella vaccine (0,0)
|
|
|
Smallpox vaccine (0,0)
|
|
|
Tetanus vaccines
(1,0)
|
|
|
Tick-borne encephalitis vaccine
(1,0)
|
|
|
Typhoid vaccines
(1,0)
|
|
|
Varicella-zoster vaccine
(2,0)
|
|
|
Yellow fever vaccine
(1,0)
|
|
14.05 |
Immunoglobulins (0,0)
|
|
|
Normal immunoglobulin (0,0)
|
|
|
Specific immunoglobulins (0,0)
|
|
|
Anti-D (Rho) immunoglobulin (0,0)
|
|
|
Interferons (0,0)
|
|
14.05.01 |
Normal immunoglobulin
(11,0)
|
|
14.05.02 |
Disease-specific immunoglobulins
(4,0)
|
|
14.05.03 |
Anti-D (Rho) immunoglobulin
(2,0)
|
|
14.06 |
International travel (0,0)
|
|
|
|
